AXTI surged +24.76% during Friday's regular session to $58.56, extending gains after already rocketing +26.97% on Thursday following blowout Q2 earnings released after Wednesday's close. Q2 results crushed estimates: revenue soared +165% YoY to $47.6M (vs. $34.1M consensus), non-GAAP EPS hit $0.19 (vs. $0.07 expected), and gross margins jumped to 45% from 8.2% a year ago.

CWEB surged approximately 25% over the past 30 days, propelled by a sharp recovery in Chinese internet stocks after a deep sell-off in May and June. Over the last quarter, the ETF remains down roughly 7%, reflecting the volatile, V-shaped trajectory that characterized the broader China internet sector during this period.

RBLX crashed -26% during Friday's regular session, compounding a -14% after-hours drop following Q2 2026 results released after Thursday's close. Q2 bookings grew just +8% YoY to $1.56B, missing consensus; DAUs of 123M and hours engaged of 29B both fell short of Street estimates.

RDDT plunged -17.60% to $146.71 during Friday's regular session, extending a decline that began in after-hours trading Thursday following the company's Q2 2026 earnings release. The selloff occurred despite Reddit delivering a strong Q2 beat — EPS of $1.25 versus $0.95 expected and revenue of $805M (+61% YoY) versus $730M consensus — and issuing Q3 guidance well above estimates.

COIN plunged -11.19% during regular trading on July 31, following a deeply disappointing Q2 2026 earnings report released after the July 30 close. The company posted a GAAP loss of $1.36 per share — far worse than the ~$0.17 per share loss analysts had modeled — on revenue of $1.22 billion, missing the $1.29 billion consensus.

SYK shares tumbled -7.74% in regular trading Friday, extending the after-hours selloff that began following Thursday's Q2 2026 earnings release after the close. The company beat Q2 estimates with adjusted EPS of $3.69 and revenue of $6.59B, but the narrow revenue beat disappointed investors given Stryker's premium valuation.

LIN dropped -5.60% during regular trading on Friday after releasing Q2 2026 results before the market open, with the selloff accelerating from a roughly -2.7% premarket decline. Q2 adjusted EPS of $4.50 narrowly beat the $4.49 consensus and revenue of $9.3 billion topped estimates, but the beat was overshadowed by weaker forward guidance.

AAPL dropped -8.48% to $305.14 during Friday's regular session, after falling sharply in after-hours and premarket trading following its fiscal Q3 earnings report released Thursday evening. The primary catalyst was weaker-than-expected September-quarter guidance: Apple forecast revenue growth of 9%–11%, below the ~12% consensus, with iPhone revenue growth guided to mid-teens versus the 17.6% analysts expected.

GUSH surged approximately 29% over the last 30 days, driven by escalating US-Iran military conflict and severe disruptions to crude oil shipments through the Strait of Hormuz. Over the past quarter, the ETF has been highly volatile — declining sharply through mid-June before rebounding on geopolitical supply fears, resulting in a net quarterly decline of roughly 5.5%.

KOLD surged approximately 27% over the past 30 days as U.S. natural gas futures tumbled below $3.00/MMBtu, reflecting the ETF's -2x daily inverse leveraged exposure to the Bloomberg Natural Gas Subindex. The quarterly trend remains positive at roughly +13%, though the bulk of gains concentrated in July as bearish supply-side catalysts intensified.

MSFU surged approximately 38% over the past 30 days, driven by a historic rally in its sole underlying holding, MSFT , following blockbuster fiscal fourth-quarter earnings. The ETF's 2X daily leveraged structure amplified Microsoft's 15.5% single-day gain on July 30 — the software giant's best daily performance since 2008.

BABX surged approximately 45% over the last 30 days, reflecting amplified 2x daily leveraged exposure to a powerful rally in Alibaba Group Holding Limited ( BABA ) shares. Over the last quarter, BABX declined roughly 22%, illustrating the extreme volatility characteristic of single-stock leveraged ETFs and the steep drawdown BABA experienced earlier in the period.

YINN surged approximately 46% over the last 30 days, reflecting a sharp V-shaped recovery in Chinese equities after a steep mid-year selloff. The rally was driven by coordinated state-backed intervention, with sovereign wealth funds deploying over 600 billion yuan into Chinese stocks and ETFs.

TSLQ surged approximately 65% over the last 30 days as Tesla ( TSLA ) experienced one of its sharpest monthly declines on record. The move was primarily driven by Tesla's Q2 2026 earnings miss, which sent TSLA shares down more than 14% in a single session on July 23 and roughly 28% for the month.

XOM is trading down approximately -1.73% in premarket action on Friday following the release of Q2 2026 results before the opening bell. The primary catalyst: adjusted EPS came in at $3.52, missing the consensus analyst estimate of approximately $3.60, despite revenue beating expectations at $116 billion.

Chime Financial stock closed at $22.60 on July 30, 2026, making the $30 target a roughly 32% climb from current levels. Wall Street consensus points directly at $30 — the median and average analyst price target — with approximately 19 analysts issuing a Moderate Buy rating.

WEX shares surged approximately 30.7% over the past 30 days, climbing from $142.59 on July 1 to $186.40 by July 30, 2026. A standout Q2 2026 earnings report on July 22 drove the bulk of gains, with revenue of $753.5 million and adjusted EPS of $5.35 handily beating analyst estimates.

Price Target in Focus: FBIN currently trades near $49.25, and the $60 level represents a psychological and technical milestone approximately 22% above the latest close. Strongest Bullish Factors: The appointment of new CEO Jesse Singh, a Truist upgrade to Buy with a $70 target, and growing conviction around a turnaround in brand-level execution support the upside case.

SentinelOne shares have moved approximately 4.6% over the last 30 days, reflecting a period of consolidation after a strong quarterly rebound from post-earnings lows. Over the broader quarter, the stock surged roughly 30%, driven by analyst upgrades, heightened M&A speculation involving major tech acquirers, and rising demand for AI-native cybersecurity solutions.

Price Target: $30.00 per share — the highest analyst price target on Wall Street, representing approximately 60% upside from the stock's recent closing price near $18.68. Strongest Bullish Factors: A robust clinical pipeline targeting the RAS/MAPK pathway, encouraging Phase 1 data for ERAS-0015, and a cash runway extending into the second half of 2028 following a sizable public offering.